Latest filing published 19 Mar 2018 for Oxford Immunotec Global PLC.
Insider track record
Richard Wenstrup: trading record in brief
This profile gathers the share dealings of Richard Wenstrup across 2 companies, led by Myriad Genetics Inc and Oxford Immunotec Global PLC. In total, 7 filings cover trades dated from 15 September 2015 to 15 March 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 19 March 2018 came the latest disclosure, a share grant in Oxford Immunotec Global PLC. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard Wenstrup
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,370 shares0Ordinary SharesSEC:0001437749-18-004971:0
- 18,622 shares0Ordinary SharesSEC:0001437749-17-013099:0
- 931 shares@ US$20.5849.6% of flowCommon StockSEC:0001645683-16-000012:0
- 931 shares@ US$20.9250.4% of flowCommon StockSEC:0001645683-16-000010:0
- 30,000 shares0Common StockSEC:0001645683-16-000008:0
- 11,500 shares0Common StockSEC:0001645683-15-000006:0
- 931 shares@ US$41.39Common StockSEC:0001645683-15-000006:1
7 of 7 declarations